Chronic Myelomonocytic Leukemia

Common Name(s)

Chronic Myelomonocytic Leukemia

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chronic Myelomonocytic Leukemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chronic Myelomonocytic Leukemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Chronic Myelomonocytic Leukemia" returned 144 free, full-text research articles on human participants. First 3 results:

Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.
 

Author(s): Li-Hong Shou, Dan Cao, Xiao-Hui Dong, Qiu Fang, Ying Wu, Yan Zhang, Ju-Ping Fei, Bao-Lian Xu

Journal:

 

This meta-analysis investigates the prognostic effect of SET binding protein 1 (SETBP1) mutations in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or chronic neutrophilic leukemia (CNL).

Last Updated: 3 Feb 2017

Go To URL
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.
 

Author(s): Chiara Elena, Anna Gallì, Esperanza Such, Manja Meggendorfer, Ulrich Germing, Ettore Rizzo, Jose Cervera, Elisabetta Molteni, Annette Fasan, Esther Schuler, Ilaria Ambaglio, Maria Lopez-Pavia, Silvia Zibellini, Andrea Kuendgen, Erica Travaglino, Reyes Sancho-Tello, Silvia Catricalà, Ana I Vicente, Torsten Haferlach, Claudia Haferlach, Guillermo F Sanz, Luca Malcovati, Mario Cazzola

Journal: Blood. 2016 Sep;128(10):1408-17.

 

Chronic myelomonocytic leukemia (CMML) is a myelodysplastic/myeloproliferative neoplasm with variable clinical course. To predict the clinical outcome, we previously developed a CMML-specific prognostic scoring system (CPSS) based on clinical parameters and cytogenetics. In this work, ...

Last Updated: 9 Sep 2016

Go To URL
Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review.
 

Author(s): Eric Grignano, Arsene Mekinian, Thorsten Braun, Eric Liozon, Mohamed Hamidou, Olivier Decaux, Xavier Puéchal, Jean Emmanuel Kahn, Yoland Schoindre, Julien Rossignol, Olivier Lortholary, Bertrand Lioger, Olivier Hermine, Sophie Park, Lionel Ades, François Montestruc, Laure Ricard, Claude Gardin, Pierre Fenaux, Olivier Fain,

Journal: Leuk. Res.. 2016 Aug;47():136-41.

 

We wanted to describe the characteristics, treatment and outcome of autoimmune and inflammatory diseases (SAIDs) associated with chronic myelomonocytic leukemia (CMML), and conducted a French multicenter retrospective study and a literature review. We included 26 cases of CMML (median ...

Last Updated: 26 Jul 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Chronic Myelomonocytic Leukemia" returned 11 free, full-text review articles on human participants. First 3 results:

Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management.
 

Author(s): Mrinal M Patnaik, Ayalew Tefferi

Journal: Am. J. Hematol.. 2016 Jun;91(6):631-42.

 

Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder characterized by overlapping features of myelodysplastic syndromes and myeloproliferative neoplasms. Diagnosis is based on the presence of persistent (>3 months) peripheral blood monocytosis (>1 × 10(9) ...

Last Updated: 17 May 2016

Go To URL
Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia.
 

Author(s): M M Patnaik, A Tefferi

Journal:

 

Chronic myelomonocytic leukemia (CMML) is a clonal stem cell disorder associated with peripheral blood monocytosis and an inherent tendency to transform to acute myeloid leukemia. CMML has overlapping features of myelodysplastic syndromes and myeloproliferative neoplasms. Clonal cytogenetic ...

Last Updated: 6 Feb 2016

Go To URL
Allogeneic hematopoietic stem cell transplantation for myelofibrosis and chronic myelomonocytic leukemia.
 

Author(s): Natasha Kekre, Vincent T Ho

Journal: Am. J. Hematol.. 2016 Jan;91(1):123-30.

 

The efficacy of hematopoietic stem cell transplantation (HSCT) is not well established in Philadelphia chromosome negative myeloproliferative neoplasms (Ph- MPNs). Without randomized prospective trials comparing HSCT to non-HSCT options or comparing HSCT regimens, physicians must ...

Last Updated: 15 Jan 2016

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

The Expression of PTEN Protein and mRNA in Malignant Cells of Chronic Myelomonocytic Leukemia
 

Status: Recruiting

Condition Summary: Chronic Myelomonocytic Leukemia

 

Last Updated: 30 Aug 2017

Go to URL
Relevance of Peripheral Cells in the Pathophysiology of Chronic Myelomonocytic Leukemia (CMML)
 

Status: Recruiting

Condition Summary: Chronic Myelomonocytic Leukemia

 

Last Updated: 12 Sep 2017

Go to URL
Study of Lenzilumab (KB003) in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)
 

Status: Recruiting

Condition Summary: Chronic Myelomonocytic Leukemia (CMML)

 

Last Updated: 13 Mar 2017

Go to URL